HighTower Advisors’s Catalyst Pharmaceutical CPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-81,340
| Closed | -$1.97M | – | 3604 |
|
|
2025
Q1 | $1.97M | Buy |
+81,340
| New | +$1.97M | ﹤0.01% | 1531 |
|
|
2021
Q3 | – | Sell |
-22,751
| Closed | -$132K | – | 2983 |
|
|
2021
Q2 | $132K | Buy |
+22,751
| New | +$132K | ﹤0.01% | 2737 |
|
|
2020
Q3 | – | Sell |
-11,042
| Closed | -$50K | – | 2337 |
|
|
2020
Q2 | $50K | Hold |
11,042
| – | – | ﹤0.01% | 2152 |
|
|
2020
Q1 | $43K | Buy |
11,042
+131
| +1% | +$510 | ﹤0.01% | 1987 |
|
|
2019
Q4 | $42K | Buy |
10,911
+500
| +5% | +$1.93K | ﹤0.01% | 2095 |
|
|
2019
Q3 | $56K | Buy |
+10,411
| New | +$56K | ﹤0.01% | 2191 |
|
|
2018
Q4 | – | Sell |
-12,411
| Closed | -$47K | – | 2102 |
|
|
2018
Q3 | $47K | Hold |
12,411
| – | – | ﹤0.01% | 2097 |
|
|
2018
Q2 | $38K | Buy |
12,411
+1,000
| +9% | +$3.06K | ﹤0.01% | 2057 |
|
|
2018
Q1 | $28K | Buy |
11,411
+1,000
| +10% | +$2.45K | ﹤0.01% | 2021 |
|
|
2017
Q4 | $41K | Buy |
+10,411
| New | +$41K | ﹤0.01% | 2088 |
|